Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii

Journal of Zhejiang University: Science B

Volumn 10, Issue 7, 2009, Pages 512-521

  Chen, Rui ^a,b   Lu, Shao Hong ^b   Tong, Qun Bo ^b   Lou, Di ^b   Shi, Dong Yan ^a   Jia, Bing Bing ^a   Huang, Guo Ping ^a   Wang, Jin Fu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

DNA vaccine; Granule protein 4 (GRA4); Liposome; Toxoplasmagondii

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA VACCINE; GAMMA INTERFERON; GRANULE PROTEIN 4; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; LIPOSOME; PHOSPHATIDYLCHOLINE; PLASMID DNA; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEHYDRATION; DNA IMMUNIZATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REHYDRATION; SPLEEN CELL; SURVIVAL RATE; SURVIVAL TIME; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; WESTERN BLOTTING;

ANIMALS; FEMALE; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTOZOAN PROTEINS; TOXOPLASMOSIS; TREATMENT OUTCOME; VACCINES, DNA;

MUS; TOXOPLASMA GONDII;

EID: 67650588723     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B0820300     Document Type: Article

References (44)

1. Aosai, F., Mun, H.S., Norose, K., Chen, M., Hata, H., Kobayashi, M., Kiuchi, M., Stauss, H.J., Yano, A., 1999. Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii infection in mice. Microbiology and Immunology, 43(1): 87-91.
2. Bivas-Benita, M., Laloup, M., Versteyhe, S., Dewitc, J., de Braekeleerc, J., Jongertc, E., Borchard, G., 2003. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: Preparation, characterization, and preliminary in vivo studies. International Journal of Pharmaceutics, 266(1-2):17-27. [doi:10.1016/S0378-5173(03)00377-6]
3. Brown, C.R., McLeod, R., 1990. Class I MHC genes and CD 8+ T cells determine cyst numbers in Toxoplasma gondii infection. The Journal of Immunology, 145(10): 3438-3441.
4. Buxton, D., Innes, E.A., 1995. A commercial vaccine for ovine toxoplasmosis. Parasitology, 110 (s1):S11-S16. [doi:10.1017/ S003118200000144X]
5. Buxton, D., Thomson, K., Maley, S., Wright, S., Bos, H.J., 1991. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec., 129(5):89-93.
6. Caplen, N.J., Alton, E.W., Middleton, P.G., Dorin, J.R., Stevenson, B.J., Gao, X., Durham, S.R., Jeffery, P.K., Hodson, M.E., Coutelle, C., 1995. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Medicine, 1 (1):39-46. [doi:10.1038/nm0195-39]
7. Chen, H.F., Chen, G.J., Zheng, H., Guo, H., 2003. Induction of immune responses in mice by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes. Chinese Medicine Journal, 116 (10):1561-1566.
8. Chen, R., Lu, S.H., Lou, D., Lin, A.F., Zeng, X.J., Ding, Z.Y., Wen, L.Y., Ohta, N., Wang, J.F., Fu, C., 2008. Evaluation of a rapid ELISA technique for detection of circulating antigens of Toxoplasma gondii. Microbiology and Immunology, 52(3):180-187. [doi:10.1111/ j.1348-0421.2008.00020.x]
9. Cong, H., Gu, Q.M., Hong, E.Y., Wang, J.W., Zhao, Q.L., Zhou, H.Y., Li, Y., Zhang, J.Q., 2008. Multi-epitope DNA vaccine linked to the A(2)/B subunit of cholera toxin protect mice against Toxoplasma gondii. Vaccine, 26(31):3913-3921. [doi:10.1016/j.vaccine.2008.04.046]
10. Couper, K.N., Nielsen, H.V., Petersen, E., Roberts, F., Roberts, C.W., Alexander, J., 2003. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofetal transmission. Vaccine, 21(21-22):2813-2820. [doi:10.1016/S0264-410 X(03)00163-4]
11. Denkers, E.Y., Gazzinelli, R.T., 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews, 11(4):569-588.
12. Desolme, B., Mévélec, M.N., Buzoni-Gatel, D., Bout, D., 2000. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine, 18 (23): 2512-2521. [doi:10.1016/S0264-410X(00)00035-9]
13. Fachado, A., Rodriguez, A., Angel, S.O., Pinto, D., Vila, I., Acosta, A., Amendoeira, R.M., Lannes-Vieira, J., 2003. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine, 21 (13-14): 1327-1335. [doi:10.1016/S0264-410X(02)00692-8]
14. Feigin, R.D., Cherry, J.D., 1998. Toxoplasmosis. In: Bergelson, J. (Ed.), Textbook of Pediatric Infectious Diseases, 4th Ed. WB Saunders, Philadelphia, p.2921.
15. Gaku, S., Takachika, H., Yoko, N., Kenji, S., Kohich, I., Yoshiki, S., Hidemi, T., Mitsuo, H., Jun, K., Hiroshi, K., 2003. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. The Journal of Immunology, 170: 495-502.
16. Golkar, M., Shokrgozar, M.A., Rafati, S., Musset, K., Assmar, M., Sadaie, R., Cesbron-Delauw, M.F., Mercier, C., 2007. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine, 25(21):4301-4311. [doi:10.1016/ j.vaccine.2007.02.057]
17. Gregoriadis, G., Saffie, R., Hart, S.L., 1996a. High yield incorporation of plasmid DNA within liposomes: Effect on DNA integrity and transfection. Journal of Drug Targeting, 3(6):469-475. [doi:10.3109/ 10611869609015 966]
18. Gregoriadis, G., Gursel, I., Gursel, M., McCormack, B., 1996b. Liposomes as immunological adjuvants and vaccine carriers. Journal of Controlled Release, 41(1-2):49-56. [doi:10.1016/0168-3659(96)01355-7]
19. Gregoriadis, G., Bacon, A., Caparros-Wanderley, W., McCormack, B., 2002. A role for liposomes in genetic vaccination. Vaccine, 20(S5):B1-B9. [doi:10.1016/S0264-410X(02)00514-5]
20. Happe, S., Fischer, A., Heese, C.H., Reichelt, D., Gruneberg, U., Freund, M., 2002. HIV-associated cerebral toxoplasmosis: Review and retrospective analysis of 36 patients. Der Nervenarzt, 73(12):1174-1178. [doi:10.1007/s00115-002-1416-y]
21. Ismael, A.B., Sekkai, D., Collin, C., Bout, D., Mévélec, M.N., 2003. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infection and Immunity, 71(11):6222-6228. [doi:10.1128/IAI.71.11. 6222-6228.2003]
22. + T-cell immunity against fatal Toxoplasma gondii infection in mice. The Journal of Immunology, 147: 3501-3506.
23. Kirby, C., Gregoriadis, G., 1984. Dehydration-rehydration vesicles: A simple method for high yield drug entrapment in liposomes. Biotechnology, 2(11):979-984. [doi:10.1038/nbt1184-979]
24. Leyva, R., Herion, P., Saavedra, R., 2001. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitology Research, 87(1):70-79. [doi:10.1007/s004360000296]
25. Liu, F., Yang, J., Huang, L., Liu, D., 1996. New cationic lipid formulations for gene transfer. Pharmaceutical Research, 13(12):1856-1860. [doi:10.1023/A:1016041326636]
26. Martin, V., Supanitsky, A., Echeverria, P.C., Litwin, S., Tanos, T., de Roodt, A.R. Guarnera, E.A., Angel, S.O., 2004. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clinical and Diagnostic Laboratory Immunology, 11(4):704-710. [doi:10.1128/ CDLI.11.4.704-710.2004]
27. Mévélec, M.N., Chardés, T., Mercereau-Puijalon, O., Bourguin, I., Achbarou, A., Dubremetz, J.F., Bout, D., 1992. Molecular cloning of GRA4, a Toxoplasma gondii dense granule protein, recognized by mucosal IgA anti-bodies. Molecular and Biochemical Parasitology, 56(2):227-238. [doi:10.1016/0166-6851(92)90172-G]
28. Méveŕlec, M.N., Merecerau-Puijalon, O., Buzoni-Gatel, D., Bourguin, I., Chardés, T., Dubremetz, J.F., Bout, D., 1998. Mapping of B epitopes in Gra4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route. Parasite Immunology, 20: 183-195.
29. Mévélec, M.N., Bout, D., Desolme, B., Marchand, H., Magné, R., Bruneel, O., Buzoni-Gatel, D., 2005. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine, 23(36):4489-4499. [doi:10.1016/j.vaccine.2005.04.025]
30. Montgomery, D.L., Ulmer, J.B., Donnelly, J.J., Liu, M.A., 1997. DNA vaccines. Pharmacology & Therapeutics, 74(2):195-207. [doi:10.1016/ S0163-7258(97)82003-7]
31. Nigro, M., Gutierrez, A., Hoffer, A.M., Clemente, M.H., Kaufer, F., Carral, L., Martin, V., Guarnera, E.A., Angel, S.O., 2003. Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagnostic Microbiology and Infectious Disease, 47(4): 609-613. [doi:10.1016/ S0732-8893(03)00156-1]
32. + T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clinical and Experimental Immunology, 84(2): 207-212.
33. Perrie, Y., Gregoriadis, G., 2000. Liposome-entrapped plasmid DNA: characterisation studies. Biochimica et Biophysica Acta (BBA), 1475(2):125-132. [doi:10.1016/S0304-4165(00)00055-6]
34. Perrie, Y., Frederik, P.M., Gregoriadis, G., 2001. Liposome mediated DNA vaccine: The effect of vesicle composition. Vaccine, 19(23-24):3301-3310. [doi:10.1016/S0264-410X(00)00432-1]
35. Perrie, Y., McNeil, S., Vangala, A., 2003. Liposome-mediated DNA immunisation via the subcutaneous route. Journal of Drug Targeting, 11(8-10):555-563. [doi:10.1080/10611860410001670071]
36. Remington, J.S., Mcleod, R., Thulliez, P., Desmonts, G., 2006. Infection Diseases of the Fetus and Newborn Infant, 6th Ed. Elsevier Saunders, Philadelphia, p.947-1091. [doi:10.1016/B0-72-160537-0/50033-5]
37. Rolland, A.P., 1998. From genes to gene medicines: Recent advances in nonviral gene delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 15(2):143-198.
38. Schwartzman, J.D., 2001. Toxoplasmosis. Current Infectious Disease Reports, 3(1):85-89. [doi:10.1007/s11908-001-0063-y]
39. Stanley, A.C., Buxton, D., Innes, E.A., Huntley, J.F., 2004. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. Vaccine, 22(29-30):3929-3941. [doi:10.1016/j.vaccine.2004.04.022]
40. Tenter, A.M., Heckeroth, A.R., Weiss, L.M., 2000. Toxoplasma gondii from animals to humans. International Journal for Parasitology, 30(12-13):1217-1258. [doi:10.1016/S0020-7519(00)00124-7]
41. Tighe, H.M., Roman, C.M., Raz, E., 1998. Gene vaccination: Plasmid DNA is more than just a blueprint. Immunology Today, 19(2):89-97. [doi:10.1016/S0167-5699(97)01201-2]
42. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Darki, V.J., Gromkowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., et al., 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science, 259(5102):1745-1749. [doi:10.1126/ science.8456302]
43. Vercammen, M., Scorza, T., Huygen, K., de Braekeleer, J., Diet, R., Jacobs, D., 2000. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infection and Immunity, 68(1): 38-45. [doi:10.1128/IAI.68.1.38-45.2000]
44. Wheeler, C.J., Felgner, P.L., Tsai, Y.J., Marshall, J., Sukhu, L., Doh, S.G., Hartikka, J., Nietupski, J., Manthorpe, M., Nichols, M., et al., 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proceedings of the National Academy of Sciences USA, 93(21):11454-11459. [doi:10.1073/pnas.93.21.11 454]